Nuclea obtains $1 million in equity funding round

02/22/2013 | American City Business Journals

Nuclea Biotechnologies has secured $1 million in a round of equity financing from 10 investors. The Pittsfield, Mass.-based company focuses on the commercialization of cancer and diabetes diagnostic tests, including a blood-based assay that CEO Patrick Muraca said has been clinically tested for monitoring prostate cancer and other uses.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC